PER-036-99已完成未知
Double blind, comparative study to evaluate the efficacy and tolerance of Dolocordralan Forte (Diclofenac 25 mg + Acetaminophen 500 mg) vs. Acetaminophen in the Treatment of Acute Exacerbation of Knee Osteoarthritis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Patients of both sexes, over 18 years old and under 65 years old.
- •Osteoarthritis of the knee, defined by clinical symptoms (crunching and / or volume increase dependent on bone parts) and / or characteristic radiological changes.
- •Pain with / without temperature increase and / or spill.
- •Primary osteoarthrosis.
- •Not having ingested steroid or nonsteroidal anti-infammatory drugs (AlNEs) in the 2 weeks prior to the study.
- •Sign the informed consent
排除标准
- •Under 18 and over 65 years old.
- •Pregnancy or breastfeeding.
- •History of gastrointestinal bleeding or Active Aetiopic Disease.
- •Hepatic and / or renal insufficiency.
- •Bronchospasm.
- •Blood dyscrasias or treatment with anticoagulants.
- •Allergy to diclofenac and / or acetaminophen.
- •Intra-articular infiltration in the last 4 weeks.
- •Have swallowed anti-inflammatories in the previous 2 weeks.
- •Uncontrolled arterial hypertension.
研究者
相似试验
进行中（未招募）
不适用
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment withDenosumab versus Alendronate Sodium in Postmenopausal Women with LowBone Mineral DensityPostmenopausal osteoporosis /osteopeniaEUCTR2005-005081-37-DEAmgen Inc1,100
进行中（未招募）
不适用
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment withDenosumab versus Alendronate Sodium in Postmenopausal Women with LowBone Mineral DensityPostmenopausal osteoporosis /osteopeniaEUCTR2005-005081-37-BEAmgen Inc1,100
进行中（未招募）
不适用
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment withDenosumab versus Alendronate Sodium in Postmenopausal Women with LowBone Mineral DensityPostmenopausal osteoporosis /osteopeniaEUCTR2005-005081-37-DKAmgen Inc1,100
进行中（未招募）
1 期
A Randomized, Double-Blind Study to Compare the Efficacy of Treatment with Denosumab versus Alendronate Sodium in Postmenopausal Women with Low Bone Mineral DensityPostmenopausal osteoporosis /osteopeniaEUCTR2005-005081-37-GBAmgen Inc1,100
终止
4 期
A controlled trial of Casein Phosphopeptide - Amorphous Calcium Phosphate (CPP-ACP) toothpaste in 6 year old childreOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonDental cariesACTRN12615001227583The University of Queensland, School of Dentistry600